Clinical research heroes: Mitsu Rana
Mitsu Rana, Senior Director of Project Management, ICON plc
PharmaTimes Magazine
PharmaTimes is the UK's leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Digital edition sponsored by
Magazine highlights
View more from the latest edition
Why healthcare still hasn’t cracked Gen Z
The world of healthcare is a long way off cracking how to communicate with Gen Z adolescents
Responding to the explosion of mobile & digital health across international markets
Kathleen O’Brien reflects on the wider considerations of a digital drug development and health management ecosystem that straddles international boundaries
MAGAZINE EXCLUSIVE
It’s time to make non-clinical differentiation a strategic priority
What will it take to transform Beyond the Pill from optional industry extra to essential market opportunity?
Developing talent in the fast-changing clinical research environment
Ulrike Lorch explores how investing in the progress of the clinical research workforce is crucial to delivering high quality, cutting-edge trials and achieving faster drug development that patients ultimately benefit from
Putting digitally empowered patients at the core of rare cancer research
Patient-centricity in pharma is of the moment, but in the rare disease space it has been a reality for many years
Branding the pandemic
What should the big pharma brands do next?
The future of health technology evaluation
Exploring The National Institute for Health and Care Excellence's (NICE) proposed update to its approach to health technology assessment (HTA)
MAGAZINE EXCLUSIVE
